Jeff is a seasoned entrepreneur with over 20 years of experience in the life sciences and software industries. A founder of multiple ventures, including Scaffold Therapeutics and Arxspan (acquired by Bruker), he is a graduate of the University of Massachusetts Amherst. Colleagues describe him as extremely intelligent, highly motivated, and an exceptional talent.
Passionate about fostering a vibrant local business environment, Jeff is a vocal supporter of the Boston biotech ecosystem. He actively promotes local companies and advocates for keeping research and development within the community to ensure its continued growth and leadership in the life sciences.
He is a co-inventor on a U. S. Patent for a directory attribute rule enforcer from his time as a contractor at AT&T Wireless.
Read the full overview →They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to analyze every situation thoroughly.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.